Anastrozole, commonly known by the brand name Arimidex, is an aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer, particularly in postmenopausal women. It works by reducing estrogen levels, thereby slowing or stopping the growth of estrogen-dependent breast cancers.
The global Anastrozole tablets market is poised for steady growth, driven by several key factors. As the primary dosage form, it is widely used in medical settings, driving demand for its superior anti-estrogen and weight loss properties.
The global Anastrozole tablets market is expected to grow at a significant CAGR of 4.2% from 2024 to 2031. This growth is driven by the increasing prevalence of hormone receptor-positive breast cancer, such as advanced age and high-grade tumors, which are widespread in this segment due to their ability to shrink the blood vessels and increase the risk of blood clot issues.
Thestra's medical department is well-known for its arrangement of clinical sites and research institutions. The department also has the largest collection of medical students' and faculty members, offering thorough training in medical technologies and disorders.
The company's post-doctoral research programmes encompass areas such as Oncology, Oncology and Oncology Immunology, as well as Respiratory, Cardiovascular and Diabetes. The company also develops and manufactures medical diagnostics and biomarkers.
The growth of the Anastrozole tablets market is driven by several key drivers. The adoption of brand-name drugs increases market demand, driving growth. The growing presence of healthcare infrastructure across Asia-Pacific also furtherrossays this market.
The market is segmented based on CPT, therapeutic indication, therapeutic area, demand factors, and geographical distribution.
The Asia-Pacific region plays a crucial role in the market. The Asia-Pacific region is expected to grow at a CAGR of 4.2% from 2023 to 2031. The region's well-established healthcare infrastructure also extends its market share.
The global Anastrozole tablets market, which includes branded and generic versions, is highly profitable. According to H. I. M. C. S. (Head of Economic Analysis), which is a leading authority on financial analysis, Anastrozole tablets led the market with a CAGR of 4.2% from 2024 to 2031.
Arimidex 1 Tablet is used to treat breast cancer in women who have gone through menopause (cessation of menses periods). Breast cancer is a type of cancer that develops in breast cells stimulated by the female sex hormone known as estrogen.
Arimidex 1 Tablet works by blocking the aromatase enzyme, which is involved in producing the estrogen hormone. The cancer cells require estrogen for their growth. Hence, by blocking the aromatase enzyme, Arimidex 1 Tablet prevents the growth of cancer cells. Together, Arimidex 1 Tablet helps prevent or stop the growth of tumours (cancer cells) in other body parts.
Take Arimidex 1 Tablet as prescribed by your doctor. Depending on your medical conditions, you are advised to take Arimidex 1 Tablet for as long as your doctor prescribes it. In some cases, you may experience common side effects such as headache, musculoskeletal (bone, muscle, or joint) pain, hot flashes, nausea, skin rashes, osteoporosis, and weakness. Do not hesitate to talk with your doctor if you persistently experience any of these side effects.
To treat your condition effectually, continue taking Arimidex 1 Tablet for as long as your doctor has prescribed. Do not stop Arimidex 1 Tablet midway. Talk to your doctor before taking Arimidex 1 Tablet if you have allergies, osteoporosis (thinning of bones), bone fractures, high levels of cholesterol, or severe liver or kidney disease. Avoid taking Arimidex 1 Tablet if you are pregnant or breastfeeding. Arimidex 1 Tablet causes weakness and dizziness, so drive only if you are alert. Arimidex 1 Tablet should not be given to children as safety has not been established. Avoid consuming alcohol with Arimidex 1 Tablet as it could lead to increased drowsiness and dizziness. Inform your doctor about your health condition and medications before taking Arimidex 1 Tablet to rule out any side effects.
arma-registered?Yes, we can prescribe Arimidex 1 Tablet Online in your country. You can also order it from our UK online pharmacy in the UK. Our UK online pharmacy is currently not available in our UK online pharmacy (utters prescription) as of this new year, we are not permitted to give Arimidex 1 Tablet to patients in our pharmacy.
Arimidex 1 Tablet Dosage|| || Common Side Effects |
| Possible Side Effects |
| Possible Side Effects (in combination with other drugs) |
| Possible Side Effects (with other drugs) |
Arimidex 1 Tablet is used to treat breast cancer in women who have gone through menopause (cessation of periods). Together, Arimidex 1 Tablet helps prevent the growth of tumour cells in other body parts.
Your doctor has prescribed Arimidex 1 Tablet is:
Pharmacology:Pharmacodynamics:Anastrozole (ARIMIDEX) is a potent and highly selective non-steroidal aromatase inhibitor. In postmenopausal women, estradiol is produced primarily from the conversion of androstenedione to estrone through the aromatase enzyme complex in peripheral tissues. Estrone is subsequently converted to estradiol. Reducing circulating estradiol levels has been shown to produce a beneficial effect in women with breast cancer. In postmenopausal women, Anastrozole (ARIMIDEX) at a daily dose of 1 mg produced estradiol suppression of greater than 80% using a highly sensitive assay. Anastrozole (ARIMIDEX) does not possess progestogenic, androgenic or estrogenic activity. Daily doses of Anastrozole (ARIMIDEX) up to 10 mg do not have any effect on cortisol or aldosterone secretion, measured before or after standard ACTH challenge testing. Corticoid supplements are therefore not needed. An extensive phase III clinical study programme showed that Anastrozole (ARIMIDEX) is an effective treatment of early breast cancer and advanced breast cancer in postmenopausal women suitable for endocrine therapy.Primary adjuvant treatment of early breast cancer:In a large phase III study conducted in 9366 postmenopausal women with operable breast cancer treated for 5 years, Anastrozole (ARIMIDEX) was shown to be statistically superior to tamoxifen in disease free survival. A greater magnitude of benefit was observed for disease free survival in favour of Anastrozole (ARIMIDEX) versus tamoxifen for the prospectively defined hormone receptor positive population. Anastrozole (ARIMIDEX) was statistically superior to tamoxifen in time to recurrence. The difference was of greater magnitude than in disease free survival for both the Intention-To-Treat (ITT) population and hormone receptor positive population. Anastrozole (ARIMIDEX) was statistically superior to tamoxifen in terms of time to distant recurrence. There was also a numerical trend in favour of Anastrozole (ARIMIDEX) for distant disease free survival. The incidence of contralateral breast cancer was statistically reduced for Anastrozole (ARIMIDEX) compared to tamoxifen. The overall survival benefit of tamoxifen was maintained with Anastrozole (ARIMIDEX). The additional analysis of time to death following recurrence showed a numerical trend in favour of Anastrozole (ARIMIDEX) compared to tamoxifen. Overall, Anastrozole (ARIMIDEX) was well tolerated. The following adverse events were reported regardless of causality. Patients receiving Anastrozole (ARIMIDEX) had a decrease in hot flushes, vaginal bleeding, vaginal discharge, endometrial cancer, venous thromboembolic events and ischemic cerebrovascular events compared with patients receiving tamoxifen. Patients receiving Anastrozole (ARIMIDEX) had an increase in joint disorders (including arthritis, arthrosis and arthralgia) and fractures compared with patients receiving tamoxifen. A fracture rate of 22 per 1000 patient years was observed on Anastrozole (ARIMIDEX) and 15 per 1000 patient years with the tamoxifen group with a median follow up of 68 months. The fracture rate for Anastrozole (ARIMIDEX) was 51 per 1000 patient years. A fracture was reported by up to 50% of patients receiving Anastrozole (ARIMIDEX) during a 46-month duration of therapy. The above effects are less common for fractures]. CONTAINS CARDIAC CARDIAC TREATMENT CARDIAC CARDIAC TREATAL, INC. CARDIAC TREATAL, INC. CARDIAC TREATAL INC.
Arimidex 1 Tablet is used to treat breast cancer in women who have gone through menopause (cessation of menses periods). Breast cancer is a type of cancer that develops in breast cells stimulated by the female sex hormone known as estrogen.
Arimidex 1 Tablet works by blocking the aromatase enzyme, which is involved in producing the estrogen hormone. The cancer cells require estrogen for their growth. Hence, by blocking the aromatase enzyme, Arimidex 1 Tablet prevents the growth of cancer cells. Together, Arimidex 1 Tablet helps prevent or stop the growth of tumours (cancer cells) in other body parts.
Take Arimidex 1 Tablet as prescribed by your doctor. Depending on your medical conditions, you are advised to take Arimidex 1 Tablet for as long as your doctor prescribes it. In some cases, you may experience common side effects such as headache, musculoskeletal (bone, muscle, or joint) pain, hot flashes, nausea, skin rashes, osteoporosis, and weakness. Do not hesitate to talk with your doctor if you persistently experience any of these side effects.
To treat your condition effectually, continue taking Arimidex 1 Tablet for as long as your doctor has prescribed. Do not stop Arimidex 1 Tablet midway. Talk to your doctor before taking Arimidex 1 Tablet if you have allergies, osteoporosis (thinning of bones), bone fractures, high levels of cholesterol, or severe liver or kidney disease. Avoid taking Arimidex 1 Tablet if you are pregnant or breastfeeding. Arimidex 1 Tablet causes weakness and dizziness, so drive only if you are alert. Arimidex 1 Tablet should not be given to children as safety has not been established. Avoid consuming alcohol with Arimidex 1 Tablet as it could lead to increased drowsiness and dizziness. Inform your doctor about your health condition and medications before taking Arimidex 1 Tablet to rule out any side effects.
Read MorepH Calcium is a natural known by the name of Calcium. Calcium is a resource for making your well-being more stable. It's also used to improve levels of fat-soluble vitamins (A, D, E) and K (all vitamins). Read MoreRead More to know more about Taking Calcium as a Medicine. Arimidex 1 Tablet is a prescription medicine that's used to treat breast cancer in women who have gone through menopause (cessation of periods). Breast cancer is a type of cancer that develops in (a) breast cells stimulated by the female sex hormone estrogen, and (c) a virus called herpes simplex that causes cold sores can pass through (skin). There are several types of herpes simplex, namely varicella-zoster virus, cytomegalovirus, and herpes simplex virus. The sores that cause cold sores are usually not cancerous, but they can cause shingles or painful, debilitating, and uncomfortable sensations in the skin causing a rash, itching, or blisters.Arimidex 1 Tablet is not recommended for use in children or adolescents. It's also not recommended for use in children or adolescents after having received a prescription from a doctor or having a health condition. Tell your doctor if you have any other medical conditions, or if you're taking any prescription or OTC medications. Do not start, stop, or change the dosage of any medicines while taking Arimidex 1 Tablet, as they may affect each other's strength and effectiveness.
Read Morerindionam 1% w/wDizziness, Nausea, and Vomiting Headache, Nasal Congestion, Dry Mouth, Dizziness, Dyspepsia Vaginal, Flushing, Indigestion Headache, Mood changes, Upset stomach, Constipation, Diarrhea, Dizziness, Nausea, Stuffy nose, Genital infections, High blood pressure, Heart problems, High cholesterol, fats (olaemia or congenital cardiac dysrhythmia), Low blood pressure, Mania, Irregular heartbeat, Osteoporosis, Weakness, Depression, Diarrhea, Pheec hyperupta, Hepatobiliary colestipulants (statins) and Bupivacaine 0.1% 0.
Stade de France Pharmacy